Steroidogenesis of the testis - new genes and pathways

Annales d'Endocrinologie

Volumn 75, Issue 2, 2014, Pages 40-47

  Flück, Christa E ^a   Pandey, Amit V ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

AKR1C2 4 genes; CYP11A1; CYP17A1; Disorder of sexual development; HSD17B3; HSD3B2; Lipoid congenital adrenal hyperplasia; POR and CYB5 deficiencies; SRD5A2

Indexed keywords

ANDROGEN; CYTOCHROME P450 17; CYTOCHROME P450 17A1; PRASTERONE; STEROID; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; CHOLESTEROL;

AKR1C2 GENE; AKR1C4 GENE; ANDROGEN SYNTHESIS; ARTICLE; CYB5 GENE; CYP11A1 GENE; CYP17A1 GENE; DISORDER OF SEX DEVELOPMENT; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC CODE; HSD17B3 GENE; HSD3B2 GENE; HUMAN; KARYOTYPE 46,XY; POR GENE; SRD5A2 GENE; STAR GENE; STEROIDOGENESIS; ADRENAL INSUFFICIENCY; ANIMAL; BIOSYNTHESIS; CONGENITAL ADRENAL HYPERPLASIA; EMBRYOLOGY; FEMALE; GENETIC ASSOCIATION; GENETICS; GONADAL DISEASE; MALE; METABOLISM; MUTATION; SEX DIFFERENTIATION; TESTIS; XY GONADAL DYSGENESIS;

46, XY DISORDERS OF SEX DEVELOPMENT; ADRENAL HYPERPLASIA, CONGENITAL; ADRENAL INSUFFICIENCY; ANDROGENS; ANIMALS; CHOLESTEROL; FEMALE; GENETIC ASSOCIATION STUDIES; GONADAL DYSGENESIS, 46,XY; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MUTATION; SEX DIFFERENTIATION; TESTIS; VIRILISM;

EID: 84901270079     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2014.03.002     Document Type: Article

References (25)

1. Matsumoto A.M., Bremner W.J. Testicular disorders. Williams textbook of endocrinology 2011, 688-816. Elsevier Saunders, Philadelphia. 12 ed. S. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg (Eds.).
2. Forest M.G., Cathiard A.M., Bertrand J.A. Evidence of testicular activity in early infancy. J Clin Endocrinol Metab 1973, 37:148-151.
3. Auchus R.J. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004, 15:432-438.
4. Wilson J.D., Auchus R.J., Leihy M.W., Guryev O.L., Estabrook R.W., Osborn S.M., et al. 5α-androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17β-diol-20-one as a key intermediate. Endocrinology 2003, 144:575-580.
5. Biason-Lauber A., Miller W.L., Pandey A.V., Fluck C.E. Of marsupials and men: "Backdoor" dihydrotestosterone synthesis in male sexual differentiation. Mol Cell Endocrinol 2013, 371:124-132.
6. Fluck C.E., Meyer-Boni M., Pandey A.V., Kempna P., Miller W.L., Schoenle E.J., et al. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet 2011, 89:201-218.
7. Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011, 32:81-151.
8. Fluck C.E., Miller W.L., Auchus R.J. The 17, 20 lyase activity of cytochrome P450c17 from human fetal testis favors the δ5 steroidogenic pathway. J Clin Endocrinol Metab 2003, 88:3762-3766.
9. Miller W.L., Flück C.E. Adrenal cortex and its disorders. Pediatric endocrinology 2014, Saunders, Philadelphia. 4th ed. M.A. Sperling (Ed.).
10. Prader A., Gurtner H.P. The syndrome of male pseudohermaphrodism in congenital adrenocortical hyperplasia without overproduction of androgens (adrenal male pseudohermaphrodism). Helv Paediatr Acta 1955, 10:397-412.
11. Bose H.S., Sugawara T., Strauss J.F.3rd, Miller W.L. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996, 335:1870-1878.
12. Fluck C.E., Pandey A.V., Dick B., Camats N., Fernandez-Cancio M., Clemente M., et al. Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS One 2011, 6:e20178.
13. Tajima T., Fujieda K., Kouda N., Nakae J., Miller W.L. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46, XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 2001, 86:3820-3825.
14. Bongiovanni A.M. The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J Clin Invest 1962, 41:2086-2092.
15. Miller W.L. The syndrome of 17,20 lyase deficiency. J Clin Endocrinol Metab 2012, 97:59-67.
16. Faisal Ahmed S., Iqbal A., Hughes I.A. The testosterone:androstenedione ratio in male undermasculinization. Clin Endocrinol 2000, 53:697-702.
17. Hershkovitz E., Parvari R., Wudy S.A., Hartmann M.F., Gomes L.G., Loewental N., et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20 lyase deficiency. J Clin Endocrinol Metab 2008, 93:3584-3588.
18. Idkowiak J., Randell T., Dhir V., Patel P., Shackleton C.H., Taylor N.F., et al. A missense mutation in the human cytochrome b5 gene causes 46, XY disorder of sex development due to true isolated 17,20 lyase deficiency. J Clin Endocrinol Metab 2012, 97:E465-E475.
19. Peterson R.E., Imperato-McGinley J., Gautier T., Shackleton C.H.L. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 1985, 313:1182-1191.
20. Fluck C.E., Tajima T., Pandey A.V., Arlt W., Okuhara K., Verge C.F., et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004, 36:228-230.
21. Pandey A.V., Fluck C.E. NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther 2013, 138:229-254.
22. Hershkovitz E., Parvari R., Wudy S.A., Hartmann M.F., Gomes L.G., Loewental N., et al. Apparent isolated 17,20 lyase deficiency caused by the homozygous mutation G539R in P450 oxidoreductase. J Clin Endocrinol Metab 2008, 93:3584-3588.
23. Fukami M., Homma K., Hasegawa T., Ogata T. Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development. Dev Dyn 2013, 242:320-329.
24. Kamrath C., Hochberg Z., Hartmann M.F., Remer T., Wudy S.A. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab 2012, 97:E367-E375.
25. Zachmann M. Prismatic cases: 17,20-desmolase (17,20 lyase) deficiency. J Clin Endocrinol Metab 1996, 81:457-459.